trials show avastin , which is used in several other cancers , gives women around four months extra life . the drug plus chemotherapy has now been licensed by european regulators . nearly 3,000 women are diagnosed with cervical cancer in the uk each year , and it kills around 1,000 women . patients will have access via the cancer drugs fund cdf until it is considered for routine nhs use . it has been available in england via the cdf since last march pending licensing . each year an estimated 600 women with advanced cervical cancer could benefit from avastin , costing 3,370 for a month's treatment . 